AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


The rise of designer Benzodiazepines is causing significant challenges in the medical field. Health care providers or looking for a method for closer detection and monitoring of the non-FDA-approved drugs.
Research shows that HIV and cardiovascular disease are strongly linked. To better manage diagnosis and treatment, scientists are searching for biomarkers that identify patients at high risk.

Ask the Expert

Bench Matters

Federal Insider

Focus on Mass Spectrometry

Industry Playbook

Regulatory Roundup

Special Supplement

The Sample